DGDeep Genomics Team
Deep Genomics
Last updated: February 23, 2026
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. Artificial Intelligence Biotech Healthcare
Khosla Ventures, $180M Series C in 2021, $720M valuation
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. Artificial Intelligence Biotech Healthcare
Khosla Ventures, $180M Series C in 2021, $720M valuation
- Series C • Khosla Ventures, $180M Series C in 2021, $720M valuation
Founder Intelligence Brief: Deep Genomics Team
This profile is built to help readers move from a founder name to decision-ready context. Deep Genomics Team is mapped to Deep Genomics in the Startup category, with current stage context as Series C. The primary operating market is Toronto, Ontario, Canada, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $180.00M, with the latest mapped round as Series C (Khosla Ventures, $180M Series C in 2021, $720M valuation). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Startup startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Startup industry routes and Series C stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: Canada directory.
- Stage signal: Series C funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Startup.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About Deep Genomics Team
Common questions people ask about this profile.
Who is Deep Genomics Team?
Deep Genomics Team is the founder profile listed on 100Xfounder for Deep Genomics, tracked for market signals, company intelligence, and operator-level context.
What does Deep Genomics do?
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. Artificial Intelligence Biotech Healthcare
Where is Deep Genomics based?
Deep Genomics is listed as operating from Toronto, Ontario, Canada.
What is the current funding stage of Deep Genomics?
Deep Genomics is currently categorized at Series C on 100Xfounder. Funding signal: Khosla Ventures, $180M Series C in 2021, $720M valuation
What is the latest funding round for Deep Genomics?
The latest tracked round for Deep Genomics is Series C Khosla Ventures, $180M Series C in 2021, $720M valuation. Total tracked rounds: 1.
Is Deep Genomics hiring right now?
Current hiring signal for Deep Genomics: Open Roles.
Is Deep Genomics Team's profile verified?
Yes. Deep Genomics Team's profile is marked as verified on 100Xfounder as of March 3, 2026.
How can I connect with Deep Genomics Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for www.deepgenomics.com.
What technologies are associated with Deep Genomics?
Deep Genomics is associated with AWS, React, Python, and PostgreSQL based on current profile intelligence.